A Multicenter Phase 3 Study Comparing the Diagnostic Accuracy of 99mTc EC DG SPECT/CT Versus 18F FDG PET/CT for Diagnosing and Staging Patients Who Have Clinical and Radiological (CT) Evidence Consistent With a Diagnosis of Lung Cancer
Phase of Trial: Phase III
Latest Information Update: 03 Oct 2017
Price : $35 *
At a glance
- Drugs Tc 99m ethylenedicysteine deoxyglucose (Primary) ; Fludeoxyglucose F-18
- Indications Lung cancer
- Focus Diagnostic use
- Sponsors CellPoint
- 27 Sep 2017 Planned End Date changed from 1 Apr 2017 to 1 Mar 2021.
- 27 Sep 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2020.
- 23 Sep 2015 Planned End Date changed from 1 Feb 2015 to 1 Apr 2017 as reported by ClinicalTrials.gov record.